Analysis of 1875 breast tumor samples showed that FGFR1 8p11-12 amplification occurs in 10.5% of breast cancers, associated with estrogen receptor (ER) expression and lobular breast cancer [176], and in 8.9% of a cohort of 595 breast cancer tumors [177]. This evidence concerns the gene ESR1 and breast neoplasm.